Workflow
Clinical echography study completed
icon
Search documents
C3.ai Ramps Up Partner-Led Sales Model: Can It Drive Scalable Growth?
ZACKS· 2025-06-23 14:15
Core Insights - C3.ai, Inc. is focusing on a go-to-market strategy that leverages its expanding partner ecosystem, achieving 73% of agreements through strategic partners in Q4 of fiscal 2025 [1][9] - The company signed 193 deals through its partner ecosystem in fiscal 2025, marking a 68% increase from the previous year [1][9] - In Q4, C3.ai experienced a 419% increase in partner-supported bookings, closing 59 agreements through strategic alliances [1][2][9] Partner Ecosystem - C3.ai closed 59 partner-led deals in the fiscal fourth quarter, with a significant focus on its alliance with Microsoft, which included 28 joint deals emphasizing manufacturing and chemicals [2][9] - The company is targeting over 600 accounts in collaboration with Microsoft and is also expanding partnerships with AWS, Google Cloud, and consulting firms like PwC and McKinsey QuantumBlack [4][9] Revenue and Investment - To support its channel-centric strategy, C3.ai has invested in demo licenses and enablement tools, which accounted for nearly 30% of its Q4 revenues [3] - The management is optimistic about the potential of consulting partners to enhance scalability and market penetration in future periods [4] Competitive Landscape - Compared to C3.ai, Palantir Technologies Inc. follows a more vertically integrated model, focusing on direct client engagement rather than a partner-led sales approach [5] - Snowflake Inc. is adopting a hybrid model that combines direct go-to-market strategies with strong platform partnerships, enhancing its offerings in the public sector [6][7] Financial Performance - C3.ai's shares have increased by 0.5% over the past three months, slightly outperforming the industry growth of 0.3% [8] - The company trades at a forward price-to-sales ratio of 6.50X, significantly lower than the industry average of 18.47X [11] - The Zacks Consensus Estimate for C3.ai's fiscal 2026 and 2027 earnings per share (EPS) indicates a year-over-year increase of 9.8% and 56.9%, respectively [12]
Best Growth Stocks to Buy for June 23rd
ZACKS· 2025-06-23 14:15
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today June 23rd:Great Lakes Dredge & Dock (GLDD) These company which is the largest provider of dredging services in the US conducting business to maintain and deepen shipping channels, reclaim land from the ocean, and renourish storm damaged coastline, carries a Zacks Rank #1 (Strong Buy), and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 39.1% over the last 60 days.Great L ...
UGI's AmeriGas Propane to Divest Hawaii Assets by Fiscal Q4 2025
ZACKS· 2025-06-23 14:15
Key Takeaways UGI's AmeriGas is selling Hawaii propane assets to Isle Gas, with closing expected in Q4 fiscal 2025. The deal includes 750,000 gallons of storage and a delivery fleet, with proceeds used to reduce debt. UGI aims to boost efficiency and fund growth by exiting non-core markets and cutting long-term costs.UGI Corporation (UGI) announced that its subsidiary, AmeriGas Propane, L.P. (AmeriGas), has entered into a definitive agreement to divest some of its assets in Hawaii to Isle Gas, a wholly ow ...
J&J's Drugs Get CHMP Recommendations for Blood Cancer Indications
ZACKS· 2025-06-23 14:15
Key Takeaways JNJ's Darzalex gets CHMP nod to treat high-risk smoldering multiple myeloma in adults. Imbruvica also earns CHMP support for frontline mantle cell lymphoma use with chemo. Both decisions are backed by phase III studies showing significant survival improvements.J&J (JNJ) announced that the EMA’s Committee for Medicinal Products for Human Use (“CHMP”) recommended granting label expansion to its two key products, Darzalex and Imbruvica, across separate new indications.CHMP Endorses JNJ’s Darzal ...
Accenture (ACN) Reliance on International Sales: What Investors Need to Know
ZACKS· 2025-06-23 14:15
Have you evaluated the performance of Accenture's (ACN) international operations for the quarter ending May 2025? Given the extensive global presence of this consulting company, analyzing the patterns in international revenues is crucial for understanding its financial strength and potential for growth.In the current era of a tightly interconnected global economy, the proficiency of a company to penetrate international markets significantly influences its financial health and trajectory of growth. For inves ...
Insights Into Lindsay (LNN) Q3: Wall Street Projections for Key Metrics
ZACKS· 2025-06-23 14:15
In its upcoming report, Lindsay (LNN) is predicted by Wall Street analysts to post quarterly earnings of $1.36 per share, reflecting a decline of 3.6% compared to the same period last year. Revenues are forecasted to be $162.01 million, representing a year-over-year increase of 16.4%.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.Before a company reve ...
Ahead of Nike (NKE) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
ZACKS· 2025-06-23 14:15
The upcoming report from Nike (NKE) is expected to reveal quarterly earnings of $0.11 per share, indicating a decline of 89.1% compared to the year-ago period. Analysts forecast revenues of $10.67 billion, representing a decrease of 15.4% year over year.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 2.3% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.Ahead of a company's e ...
Countdown to Acuity (AYI) Q3 Earnings: Wall Street Forecasts for Key Metrics
ZACKS· 2025-06-23 14:15
In its upcoming report, Acuity (AYI) is predicted by Wall Street analysts to post quarterly earnings of $4.31 per share, reflecting an increase of 3.9% compared to the same period last year. Revenues are forecasted to be $1.14 billion, representing a year-over-year increase of 17.5%.The current level reflects no revision in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this ...
Unlocking Q2 Potential of McCormick (MKC): Exploring Wall Street Estimates for Key Metrics
ZACKS· 2025-06-23 14:15
In its upcoming report, McCormick (MKC) is predicted by Wall Street analysts to post quarterly earnings of $0.65 per share, reflecting a decline of 5.8% compared to the same period last year. Revenues are forecasted to be $1.66 billion, representing a year-over-year increase of 1.2%.The current level reflects a downward revision of 0.1% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projec ...
Unveiling Walgreens (WBA) Q3 Outlook: Wall Street Estimates for Key Metrics
ZACKS· 2025-06-23 14:15
The upcoming report from Walgreens Boots Alliance (WBA) is expected to reveal quarterly earnings of $0.34 per share, indicating a decline of 46% compared to the year-ago period. Analysts forecast revenues of $36.66 billion, representing an increase of 0.9% year over year.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.Prior to a company's earn ...